DOUGLAS LEEMAN: Open Payments
NPI 1043390875 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,109 in 57 payments from 13 companies in 2025. Trend: 2023 $4,643 · 2024 $4,306 · 2025 $6,109
Speaker / faculty: $3,645Food & beverage: $1,255Travel & lodging: $669Speaker / faculty: $540
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $5,252 |
| Janssen Biotech, Inc. | 20 | $222 |
| Incyte Corporation | 7 | $152 |
| GENZYME CORPORATION | 6 | $149 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| PFIZER INC. | 3 | $72 |
| Almirall LLC | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| Lilly USA, LLC | 1 | $25 |
| UCB, Inc. | 1 | $21 |
Products named: ILUMYA, TREMFYA, DUPIXENT, OPZELURA, CIBINQO, Klisyri, RINVOQ, EBGLYSS.
Industry payments across FL — which companies pay providers there.
